Xtant Medical (United States)
company in Belgrade, United States
XTNT NYSE
SEC CIK 1453593 LEI 549300JOU6AK8387EW77
Follow Xtant Medical (United States)
Weekly email: filings, results
Revenue, last quarter
$24.3M
−27% vs same quarter last year
Net income
−$3.6M
−372.3% vs same quarter last year
EPS, diluted
−$0.03
−400% vs same quarter last year
Operating cash flow
−$855K
−118.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $133.9M | $5K |
| FY24 | $117.3M | −$16.4K |
| FY23 | $91.3M | $660 |
| FY22 | $58M | −$8.5M |
| FY21 | $55.3M | −$4.8M |
| FY20 | $53.3M | −$7M |
| FY19 | $64.7M | −$8.2M |
| FY18 | $72.2M | −$70.1M |
| FY17 | $82.6M | −$52.4M |
| FY16 | $90M | −$19.5M |
| FY15 | $59.3M | −$2.2M |
| FY14 | $35.3M | −$10.5M |
| FY13 | $33.1M | −$12.7M |
| FY12 | $33M | −$7.7M |
| FY11 | $30.1M | −$3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 62.9% | 5.4% | 0% |
| FY24 | 58.2% | −10.3% | 0% |
| FY23 | 60.8% | −11.1% | 0% |
| FY22 | 55.4% | −11.7% | −14.6% |
| FY21 | 58.8% | −7% | −8.8% |
| FY20 | 64.5% | −1.4% | −13.2% |
| FY19 | 65.7% | −3.5% | −12.7% |
| FY18 | 60.2% | −83.2% | −97.1% |
| FY17 | 60.6% | −45.8% | −63.4% |
| FY16 | 69.2% | −8.4% | −21.7% |
| FY15 | 65.9% | −20.4% | −3.7% |
| FY14 | 63.1% | −17.7% | −29.7% |
| FY13 | 57.1% | −27.2% | −38.4% |
| FY12 | 68.7% | −15% | −23.4% |
| FY11 | 69.8% | −21.4% | −10% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $10.2M |
| FY24 | −$16M |
| FY23 | −$11M |
| FY22 | −$7.1M |
| FY21 | −$1.7M |
| FY20 | −$2.3M |
| FY19 | −$1.3M |
| FY18 | $588K |
| FY17 | −$2.2M |
| FY16 | −$20.2M |
| FY15 | −$11.4M |
| FY14 | −$7.6M |
| FY13 | −$5.5M |
| FY12 | −$12.6M |
| FY11 | −$8.3M |
- Xtant Medical (United States)
- Healthcare median
Show the numbers
| Year | Xtant Medical (United States) | Healthcare median |
|---|---|---|
| FY25 | 0% | −30.6% |
| FY24 | 0% | −47% |
| FY23 | 0% | −58% |
| FY22 | −14.6% | −80.4% |
| FY21 | −8.8% | −71.9% |
| FY20 | −13.2% | −62.2% |
| FY19 | −12.7% | −46.3% |
| FY18 | −97.1% | −49.6% |
| FY17 | −63.4% | −45.9% |
| FY16 | −21.7% | −36% |
| FY15 | −3.7% | −38.4% |
| FY14 | −29.7% | −35.5% |
| FY13 | −38.4% | −37.1% |
| FY12 | −23.4% | −29.1% |
| FY11 | −10% | −27.9% |